GLP-1 Medications & Telehealth: The 2026 Complete Guide

GLP-1 medications — Ozempic, Wegovy, Mounjaro, Zepbound, and compounded versions — have changed the field of weight management and type 2 diabetes. This guide explains how they work, who qualifies, what they cost in 2026, and how to get prescribed online from a licensed US telehealth provider.

Researched and written by the GLP Insights editorial team · Last updated May 1, 2026 · Reviewed against FDA prescribing information and published clinical trials.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1, a hormone released by L-cells in the small intestine after a meal. It tells the pancreas to release insulin, slows gastric emptying, and signals satiety to the brain. The natural hormone only lasts a few minutes before enzymes break it down. GLP-1 medications are synthetic peptides engineered to resist that breakdown — so a single weekly injection produces hours-to-days of effect.

The category includes GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, exenatide, lixisenatide) and dual GIP/GLP-1 receptor agonists (tirzepatide). All are prescription drugs in the United States; some are FDA-approved for type 2 diabetes, some for chronic weight management, and some for both.

For a fuller mechanism walkthrough, see What Is GLP-1?.

How GLP-1 Works in the Body

Three actions explain most of what GLP-1 medications do:

1. Glucose-dependent insulin release. When blood sugar is high after eating, GLP-1 amplifies insulin secretion. When blood sugar is normal, it does not — so the hypoglycemia risk is low when used alone.
2. Suppressed glucagon. GLP-1 lowers glucagon, which reduces the liver's release of stored sugar.
3. Delayed gastric emptying and central satiety. Food stays in the stomach longer, and brain receptors signal fullness sooner — so most people eat less without conscious effort.

The net effect over months is improved HbA1c in diabetes and significant body weight reduction in obesity. The STEP-1 trial (NEJM 2021) showed semaglutide 2.4 mg weekly produced about 15% mean body weight loss at 68 weeks. SURMOUNT-1 (NEJM 2022) showed tirzepatide 15 mg weekly produced about 22% at 72 weeks.

GLP-1 Medications Available in 2026

Eight FDA-approved GLP-1 receptor agonists are currently sold in the United States, plus compounded versions of semaglutide and tirzepatide produced by licensed compounding pharmacies. The list below covers what you'll encounter on a typical telehealth or pharmacy visit.

For a deeper comparison, see All GLP-1 Drugs and Which GLP-1 Works Best for Weight Loss.

GLP-1 for Weight Loss vs Diabetes: FDA Approval Map

What GLP-1 Costs in 2026

Brand-name GLP-1s list at roughly $1,000–1,350 per month before insurance. Cash discounts via GoodRx, Costco, or manufacturer programs may reduce this slightly but rarely bring it below $900. Compounded versions through telehealth platforms typically cost $199–499 per month, including the provider consultation.

• Brand Wegovy / Zepbound: ~$1,000–1,350/month list
• Brand Ozempic / Mounjaro / Trulicity / Rybelsus: ~$950–1,070/month list
• Compounded semaglutide via telehealth: ~$199–399/month
• Compounded tirzepatide via telehealth: ~$299–499/month

Insurance coverage is more reliable for diabetes than weight loss alone, though recent CMS updates have begun expanding Wegovy coverage for cardiovascular indications. Full pricing detail on GLP-1 Cost and Medicare Coverage.

Side Effects: What to Actually Expect

Most side effects on GLP-1 medications are gastrointestinal and dose-dependent. Slow titration — the standard approach — reduces them. The most common are:

• Nausea (15–45% of patients in trials)
• Diarrhea or constipation
• Vomiting (less common after first few weeks)
• Abdominal pain and reflux
• Reduced appetite (often the desired effect, but uncomfortable for some)
• Fatigue and headaches in the first few weeks

Less common but more serious risks include pancreatitis, gallbladder events, severe hypoglycemia (when combined with insulin or sulfonylureas), and the FDA boxed warning regarding thyroid C-cell tumors observed in rodents. People with a history of medullary thyroid carcinoma or MEN-2 should not take GLP-1s. Full detail on side effects.

How to Get GLP-1 Online: 4 Steps

1. Consult. Complete a brief intake form (medical history, current medications, BMI, goals) and book a video visit with a licensed clinician — usually within the same week.
2. Prescribe. If you meet the medical criteria and have no contraindications, the clinician prescribes either a brand-name GLP-1 or a compounded version.
3. Deliver. Medication ships from a partner pharmacy (compounding pharmacy for compounded preparations) usually within 5–10 business days. Brand medications can be sent to a local pharmacy.
4. Follow up. Your provider checks in monthly to adjust dose, manage side effects, and confirm progress.

Full walkthrough on How to Get GLP-1 Prescribed Online.

Telehealth vs In-Person Clinic: Honest Comparison

Compounded vs Brand-Name: Quick Answer

Compounded semaglutide and tirzepatide contain the same active molecules as their brand counterparts (Wegovy / Zepbound). They are made by licensed US compounding pharmacies, generally allowed during periods of FDA-listed shortage. Cost is one-quarter to one-half of brand. Quality depends on the compounding pharmacy's accreditation and sourcing of the active pharmaceutical ingredient — reputable telehealth providers work only with accredited 503A or 503B pharmacies. Full detail on compounded semaglutide and compounded tirzepatide.

Sources & Medical References

• Wilding et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). N Engl J Med 2021;384:989-1002. DOI link
• Jastreboff et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205-216. DOI link
• FDA prescribing information for Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza, Trulicity. accessdata.fda.gov
• FDA Drug Shortages list. FDA shortage database